Immunological Factors in Reproductive Health

The interplay between the maternal immune system and reproductive processes is critical for successful conception, embryo implantation and maintenance of pregnancy. Innate immune cells, including uterine natural killer (NK) cells and macrophages, mediate trophoblast invasion and early placental development, while adaptive elements such as regulatory T cells (Tregs) ensure tolerance towards the semi-allogeneic foetus. A balanced profile of pro- and anti-inflammatory cytokines supports endometrial receptivity and vascular remodelling, whereas dysregulation of these mediators can contribute to implantation failure, recurrent pregnancy loss (RPL) and other reproductive disorders. Autoantibodies, complement activation and aberrant antigen presentation further shape pregnancy outcomes. Advances in diagnostic assays and immunomodulatory therapies are translating basic insights into predictive models and personalised interventions, with the potential to improve assisted reproduction success rates and reduce miscarriage risks worldwide.

Research from Nature Portfolio

Recent studies have applied machine learning to large cohorts of patients with RPL, integrating clinical features and routine laboratory data to stratify risk classes with high accuracy and objectivity. Such approaches facilitate early identification of individuals at greatest risk of recurrent loss and support data-driven clinical decision-making. In parallel, preclinical research in murine models has explored the therapeutic potential of tregitopes—specific self-derived IgG epitopes that expand Tregs and promote interleukin-10 production. Administration of these peptides in abortion-prone matings reduced foetal death rates and preserved a tolerogenic phenotype in antigen-presenting cells, pointing to a novel alternative to broad-spectrum immunoglobulin therapies.

Immunological Factors in Reproductive Health publication trend

The graph below shows the total number of articles in immunological factors in reproductive health across all publications each year (not limited to Nature Index journals).

Technical terms

Cytokines: Small proteins released by immune and non-immune cells that regulate inflammation, cell growth and communication in reproductive tissues.

Regulatory T cells (Tregs): A subset of CD4+ T lymphocytes that suppress immune responses and promote tolerance towards the foetus.

Natural killer (NK) cells: Innate lymphocytes abundant in the uterine lining that support placental development and modulate trophoblast invasion.

Antinuclear antibodies (ANA): Autoantibodies targeting nuclear antigens, sometimes investigated in women with recurrent pregnancy loss.

Tregitopes: Peptide epitopes derived from IgG that preferentially expand regulatory T cells and enhance tolerance.

Recurrent implantation failure (RIF): The absence of pregnancy after multiple embryo transfers in assisted reproductive cycles despite high-quality embryos.

Machine learning (ML): Computational methods that detect patterns in complex clinical data to predict patient outcomes or stratify risk in reproductive medicine.

References

1. Pro- and anti-inflammatory cytokines and growth factors in patients undergoing in vitro fertilization procedure treated with prednisone. Frontiers in Immunology (2023).
2. Association between antinuclear antibodies and pregnancy prognosis in recurrent pregnancy loss patients. Human Reproduction (2024).
3. Predictive models of recurrent implantation failure in patients receiving ART treatment based on clinical features and routine laboratory data. Reproductive Biology and Endocrinology (2024).
4. Machine Learning (ML) based-method applied in recurrent pregnancy loss (RPL) patients diagnostic work-up: a potential innovation in common clinical practice. Scientific Reports (2020).
5. Tregitopes regulate the tolerogenic immune response and decrease the foetal death rate in abortion-prone mouse matings. Scientific Reports (2020).